From Search to Manuscript in Hours.
The world's first complete AI-powered systematic review & meta-analysis platform. 8 AI pipelines. Real statistical engine. Publication-quality output.
No credit card required · 100 credits free
0+
Researchers
0+
Papers Screened
0+
Reviews Completed
0
Countries
Complete Workflow, Fully Automated
Every stage of a systematic review — automated, auditable, reproducible.
Search & Import
AI generates PubMed queries from PICO. Import from 11+ formats.
AI Screening
Screen thousands of titles & abstracts. 12 refs/batch, 10 concurrent.
Full-Text Review
Auto-retrieve PDFs from 15+ sources. Dual-pass AI screening.
Data Extraction
Multi-modal extraction from text, tables & figures. 24 data types.
Risk of Bias
10 tools: ROB 2, ROBINS-I, NOS, JBI, QUADAS-2, AMSTAR-2+.
Meta-Analysis
11 effect sizes, 7 tau² estimators, interactive forest & funnel plots.
GRADE & Synthesis
Evidence certainty assessment, Summary of Findings tables.
Manuscript
AI generates publication-quality manuscript with real citations.
Why Researchers Choose ResBot
Not another screening tool. A complete platform from search to manuscript.
Multi-Model AI Pipeline
4-tier model strategy via OpenRouter. Fast screening, precise extraction, independent chain review.
Real Statistical Engine
Deterministic pooling — DerSimonian-Laird, HAKN correction, prediction intervals. Real math, not AI guesses.
Auditable & Transparent
Every AI decision has provenance, evidence, and confidence. Click any judgment to see the source.
Hours, Not Months
Screen 5,000 papers in under 10 minutes. Complete reviews in days instead of months.
PRISMA 2020 Compliant
27/27 PRISMA items including Funding, COI, Data Availability. Export DOCX, LaTeX, XLSX.
Publication Quality
Forest plots, funnel plots, PRISMA flow diagrams, formatted manuscripts for journal submission.
How ResBot Compares
Capability-by-capability against the leading systematic-review platforms — Covidence, DistillerSR, Rayyan, and Nested Knowledge.
| Capability | ResBot.aiEnd-to-end AI | CovidenceCochrane-endorsed | DistillerSREnterprise SR | RayyanFree screening | Nested KnowledgeLiving reviews |
|---|---|---|---|---|---|
01Search & Discovery | |||||
| AI PICO query generation | |||||
| Multi-database search (PubMed, Scopus…) | |||||
| Reference import (RIS · EndNote · BibTeX) | |||||
02Screening | |||||
| AI title & abstract screening | |||||
| Dual-pass / chain review | |||||
| Inter-rater reliability metrics | |||||
03Full-Text Pipeline | |||||
| Automatic PDF retrieval (15+ sources) | |||||
| OCR for scanned PDFs | |||||
| Built-in PDF viewer & annotations | |||||
04Data Extraction | |||||
| AI-powered extraction | |||||
| Multi-modal (tables · figures) | |||||
| Schema auto-discovery | |||||
05Risk of Bias | |||||
| Validated RoB tools | 10 | 1 | 5+ | 0 | 3+ |
| AI-assisted assessment | |||||
| Evidence-link provenance | |||||
06Meta-Analysis | |||||
| Built-in statistical engine | |||||
| Forest & funnel plots | |||||
| Effect-size measures supported | 11 | — | — | — | 3 |
07Synthesis & Reporting | |||||
| GRADE assessment | |||||
| PRISMA 2020 (27 / 27 items) | |||||
| AI manuscript generation | |||||
08Access | |||||
| Free tier | |||||
| Transparent pricing | |||||
Comparison based on each platform's publicly documented capabilities, last verified April 2026. Have we missed something? Let us know.
Trusted by Researchers Worldwide
“ResBot cut our systematic review timeline from 8 months to 3 weeks. The AI screening alone saved us hundreds of hours.”
Dr. Sarah Chen
Associate Professor, Epidemiology
Johns Hopkins Bloomberg School
“The meta-analysis engine produces results identical to RevMan and R. Having interactive forest plots built-in is a game changer.”
Prof. Ahmed El-Sayed
Cochrane Review Author
Cairo University
“We use ResBot for our rapid HTA reviews. The full pipeline from search to manuscript with real citations is unmatched.”
Dr. Maria Lopez
Health Technology Assessment Lead
NICE International